Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus(SLE)”

1,205 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,205 results

Testing effectiveness (Phase 2)Study completedNCT04882878
What this trial is testing

Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Janssen Research & Development, LLC 228
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Early research (Phase 1)UnknownNCT05474885
What this trial is testing

BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
iCell Gene Therapeutics 15
Not applicableStudy completedNCT00029926
What this trial is testing

Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity

Who this might be right for
Lupus ErythematosusSystemic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Early research (Phase 1)Looking for participantsNCT07031713
What this trial is testing

Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Not applicableUnknownNCT00519454
What this trial is testing

Estrogen and Gender Biased Autoimmunity

Who this might be right for
Systemic Lupus Erythematosus
The Center for Rheumatic Disease, Allergy, & Immunology 75
Large-scale testing (Phase 3)Enrolling By InvitationNCT04976322
What this trial is testing

Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma SRL 760
Post-approval studies (Phase 4)WithdrawnNCT01926054
What this trial is testing

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

Who this might be right for
SLE Glomerulonephritis Syndrome, WHO Class V
Ohio State University
Testing effectiveness (Phase 2)Ended earlyNCT05306873
What this trial is testing

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT07012239
What this trial is testing

The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE

Who this might be right for
Genetic Polymorphism
Bangladesh Medical University 348
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Testing effectiveness (Phase 2)Study completedNCT05638802
What this trial is testing

DS-7011a in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Daiichi Sankyo 26
Large-scale testing (Phase 3)UnknownNCT00432354
What this trial is testing

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Buddhist Tzu Chi General Hospital 40
Not applicableStudy completedNCT06626945
What this trial is testing

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Who this might be right for
Systemic Lupus Erythematosus (SLE)
AstraZeneca 152
Testing effectiveness (Phase 2)Ended earlyNCT02917265
What this trial is testing

Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus

Who this might be right for
Systemic Lupus Erythematosus
Aikaterini Thanou 7
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Testing effectiveness (Phase 2)Study completedNCT01072734
What this trial is testing

Auto-immunity in Lupus Patients After Influenza Vaccine

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 28
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT01753193
What this trial is testing

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

Who this might be right for
Lupus Erythematosus, Systemic
MedImmune LLC 218
Early research (Phase 1)Study completedNCT03724916
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Erythematosus, Systemic
Millennium Pharmaceuticals, Inc. 23
Load More Results